• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病大脑中补体系统的产生和激活上调。

Up-regulated production and activation of the complement system in Alzheimer's disease brain.

作者信息

Yasojima K, Schwab C, McGeer E G, McGeer P L

机构信息

Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Am J Pathol. 1999 Mar;154(3):927-36. doi: 10.1016/S0002-9440(10)65340-0.

DOI:10.1016/S0002-9440(10)65340-0
PMID:10079271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1866427/
Abstract

We used reverse transcriptase-polymerase chain reaction and Western blotting techniques to measure the levels of complement mRNAs and their protein products in Alzheimer's disease (AD) brain compared with non-AD brain. mRNAs for C1q, C1r, C1s, C2, C3, C4, C5, C6, C7, C8, and C9 were detected in the 11 regions of brain that were investigated. The mRNA levels were markedly up-regulated in affected areas of AD brain. In the entorhinal cortex, hippocampus, and midtemporal gyrus, which had dense accumulations of plaques and tangles, C1q mRNA was increased 11- to 80-fold over control levels, and C9 mRNA 10- to 27-fold. These levels were substantially higher than in the livers of the same cases. Western blot analysis of AD hippocampus established the presence of all of the native complement proteins as well as their activation products C4d, C3d, and the membrane attack complex. These data indicate that high levels of complement are being produced in affected areas of AD brain, that full activation of the classical complement pathway is continuously taking place, and that this activation may be contributing significantly to AD pathology.

摘要

我们运用逆转录聚合酶链反应和蛋白质印迹技术,来测定与非阿尔茨海默病(AD)脑相比,AD脑内补体mRNA及其蛋白质产物的水平。在所研究的脑的11个区域中检测到了C1q、C1r、C1s、C2、C3、C4、C5、C6、C7、C8和C9的mRNA。AD脑的病变区域中mRNA水平显著上调。在内嗅皮质、海马体和颞中回,这些区域有大量的斑块和缠结堆积,C1q mRNA比对照水平增加了11至80倍,C9 mRNA增加了10至27倍。这些水平显著高于同一病例肝脏中的水平。对AD海马体进行的蛋白质印迹分析证实了所有天然补体蛋白及其激活产物C4d、C3d和膜攻击复合物的存在。这些数据表明,AD脑的病变区域产生了高水平的补体,经典补体途径持续发生完全激活,并且这种激活可能对AD病理有显著影响。

相似文献

1
Up-regulated production and activation of the complement system in Alzheimer's disease brain.阿尔茨海默病大脑中补体系统的产生和激活上调。
Am J Pathol. 1999 Mar;154(3):927-36. doi: 10.1016/S0002-9440(10)65340-0.
2
Expression of complement messenger RNAs and proteins by human oligodendroglial cells.人少突胶质细胞中补体信使核糖核酸和蛋白质的表达
Glia. 2003 Jun;42(4):417-23. doi: 10.1002/glia.10234.
3
Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.阿尔茨海默病大脑中经典途径补体蛋白的mRNA的神经元表达。
Brain Res. 1997 Sep 26;769(2):391-5. doi: 10.1016/s0006-8993(97)00850-0.
4
Human heart generates complement proteins that are upregulated and activated after myocardial infarction.人类心脏会产生补体蛋白,这些蛋白在心肌梗死后会被上调并激活。
Circ Res. 1998 Oct 19;83(8):860-9. doi: 10.1161/01.res.83.8.860.
5
Early complement components in Alzheimer's disease brains.阿尔茨海默病大脑中的早期补体成分。
Acta Neuropathol. 1996;91(1):53-60. doi: 10.1007/s004019570001.
6
Early complement activation increases in the brain in some aged normal subjects.在一些老年正常受试者中,大脑中的早期补体激活增加。
Neurobiol Aging. 2004 Sep;25(8):1001-7. doi: 10.1016/j.neurobiolaging.2003.11.003.
7
Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.与阿尔茨海默病大脑中淀粉样斑块相关的细胞因子刺激人类神经胶质细胞和神经元细胞培养物分泌早期补体蛋白,但不分泌C1抑制剂。
Exp Neurol. 1999 Nov;160(1):289-99. doi: 10.1006/exnr.1999.7199.
8
Neurons express proteins of the classical complement pathway in Alzheimer disease.神经元在阿尔茨海默病中表达经典补体途径的蛋白质。
Brain Res. 1997 Sep 26;769(2):385-90. doi: 10.1016/s0006-8993(97)00849-4.
9
Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease.补体调节因子C1抑制剂和CD59在阿尔茨海默病中不会显著抑制补体激活。
Brain Res. 1999 Jul 3;833(2):297-301. doi: 10.1016/s0006-8993(99)01514-0.
10
Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease.人类尸检脑源性脑血管平滑肌细胞表达经典补体途径的所有基因:脑淀粉样血管病和阿尔茨海默病中血管损伤的潜在机制。
Microvasc Res. 2008 Apr;75(3):411-9. doi: 10.1016/j.mvr.2007.10.004. Epub 2007 Nov 1.

引用本文的文献

1
Age-Related Complement C3 Drives Memory Impairments and Associated Neuropathologies in a Mouse Model.衰老相关补体C3在小鼠模型中引发记忆损伤及相关神经病理学变化。
Aging Cell. 2025 Sep;24(9):e70145. doi: 10.1111/acel.70145. Epub 2025 Jun 20.
2
Whole Transcriptome RNA-Seq Reveals Drivers of Pathological Dysfunction in a Transgenic Model of Alzheimer's Disease.全转录组RNA测序揭示阿尔茨海默病转基因模型中病理功能障碍的驱动因素。
Mol Neurobiol. 2025 Apr 5. doi: 10.1007/s12035-025-04878-6.
3
Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population.衰老认知受损人群中脑组织体积损失与炎症生物标志物白细胞介素-1β(IL1β)、磷酸化tau蛋白(P-tau)、总tau蛋白(T-tau)和NLR家族pyrin结构域包含3蛋白(NLPR3)的相关性。
Front Aging Neurosci. 2024 Jul 23;16:1388654. doi: 10.3389/fnagi.2024.1388654. eCollection 2024.
4
Organelle phenotyping and multi-dimensional microscopy identify C1q as a novel regulator of microglial function.细胞器表型分析和多维显微镜分析鉴定 C1q 为小胶质细胞功能的新型调节因子。
J Neurochem. 2024 Sep;168(9):3095-3107. doi: 10.1111/jnc.16173. Epub 2024 Jul 17.
5
Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells.阿尔茨海默病中的神经炎症:来自外周免疫细胞的见解
Immun Ageing. 2024 Jun 14;21(1):38. doi: 10.1186/s12979-024-00445-0.
6
Factor H's Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer's Disease Treatment.补体因子 H 的调控作用成为阿尔茨海默病治疗的一个重要且有前景的治疗靶点。
Int J Mol Sci. 2024 Feb 14;25(4):2272. doi: 10.3390/ijms25042272.
7
New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis.自身免疫性胶质纤维酸性蛋白性脑膜脑炎的神经病理学和发病机制的新见解。
Acta Neuropathol. 2024 Feb 3;147(1):31. doi: 10.1007/s00401-023-02678-7.
8
Associations of cerebrospinal fluid complement proteins with Alzheimer's pathology, cognition, and brain structure in non-dementia elderly.脑脊液补体蛋白与非痴呆老年人阿尔茨海默病病理、认知和大脑结构的关联。
Alzheimers Res Ther. 2024 Jan 18;16(1):12. doi: 10.1186/s13195-023-01377-5.
9
Iron and Targeted Iron Therapy in Alzheimer's Disease.阿尔茨海默病中的铁和靶向铁治疗。
Int J Mol Sci. 2023 Nov 15;24(22):16353. doi: 10.3390/ijms242216353.
10
Serum proteomic analysis in esophagectomy patients with postoperative delirium: A case-control study.食管癌术后谵妄患者血清蛋白质组学分析:一项病例对照研究。
Heart Lung. 2024 Jan-Feb;63:35-41. doi: 10.1016/j.hrtlng.2023.09.009. Epub 2023 Sep 23.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Human heart generates complement proteins that are upregulated and activated after myocardial infarction.人类心脏会产生补体蛋白,这些蛋白在心肌梗死后会被上调并激活。
Circ Res. 1998 Oct 19;83(8):860-9. doi: 10.1161/01.res.83.8.860.
3
Induced expression of neuronal membrane attack complex and cell death by Alzheimer's beta-amyloid peptide.阿尔茨海默病β-淀粉样肽诱导神经元膜攻击复合物的表达及细胞死亡。
Brain Res. 1998 Jun 15;796(1-2):187-97. doi: 10.1016/s0006-8993(98)00346-1.
4
Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion.兔心脏补体基因表达:缺血再灌注上调
Circ Res. 1998 Jun 15;82(11):1224-30. doi: 10.1161/01.res.82.11.1224.
5
Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.阿尔茨海默病大脑中经典途径补体蛋白的mRNA的神经元表达。
Brain Res. 1997 Sep 26;769(2):391-5. doi: 10.1016/s0006-8993(97)00850-0.
6
Neurons express proteins of the classical complement pathway in Alzheimer disease.神经元在阿尔茨海默病中表达经典补体途径的蛋白质。
Brain Res. 1997 Sep 26;769(2):385-90. doi: 10.1016/s0006-8993(97)00849-4.
7
Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease.阿尔茨海默病中膜攻击复合物C5b - 9的分子与细胞特征
Neurobiol Aging. 1997 Jul-Aug;18(4):415-21. doi: 10.1016/s0197-4580(97)00042-0.
8
Risk of Alzheimer's disease and duration of NSAID use.阿尔茨海默病风险与非甾体抗炎药使用时长
Neurology. 1997 Mar;48(3):626-32. doi: 10.1212/wnl.48.3.626.
9
Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles.淀粉样蛋白P免疫反应性先于C4d在细胞外神经原纤维缠结上的沉积。
Acta Neuropathol. 1997 Jan;93(1):87-92. doi: 10.1007/s004010050586.
10
Insulin receptor mRNA in the substantia nigra in Parkinson's disease.帕金森病中黑质的胰岛素受体信使核糖核酸
Neurosci Lett. 1996 Feb 9;204(3):201-4. doi: 10.1016/0304-3940(96)12357-0.